DL-Buthionine-(SR)-sulfoximine
CAS No. 5072-26-4
DL-Buthionine-(SR)-sulfoximine( Butionine sulfoximine | NSC 381100 )
Catalog No. M20963 CAS No. 5072-26-4
DL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase for the treatment of solid tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 31 | In Stock |
|
| 50MG | 43 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDL-Buthionine-(SR)-sulfoximine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase for the treatment of solid tumors.
-
DescriptionDL-Buthionine-(SR)-sulfoximine is an inhibitor of γ-glutamylcysteine synthetase for the treatment of solid tumors.
-
In Vitro——
-
In Vivo——
-
SynonymsButionine sulfoximine | NSC 381100
-
PathwayOthers
-
TargetOther Targets
-
Recptorγ-glutamylcysteine synthetase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5072-26-4
-
Formula Weight222.31
-
Molecular FormulaC8H18N2O3S
-
Purity>98% (HPLC)
-
SolubilityH2O:41.67 mg/mL (187.44 mM; Need ultrasonic)
-
SMILESCCCCS(=N)(=O)CCC(N)C(=O)O
-
Chemical Name2-amino-4-(butylsulfonimidoyl)butanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Arrick B. A . Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis[J]. Journal of Experimental Medicine 1981 153(3):720-725.
molnova catalog
related products
-
Ianalumab
Ianalumab (VAY-736) is a decarboxylated humanized antibody against BAFF-R that inhibits the interaction between BAFF and BAFF-R, blocking BAFF-mediated apoptosis protection.
-
PCNA-I1
PCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.
-
Cholecystokinin Octa...
Cholecystokinin Octapeptide (1-5) (desulfated)
Cart
sales@molnova.com